HomeInsightsStock Comparison

Novartis India Ltd vs Sanofi Consumer Healthcare India Ltd Stock Comparison

Novartis India Ltd vs Sanofi Consumer Healthcare India Ltd Stock Comparison

Last Updated on: Jul 16, 2025

Key Highlights

  • The Latest Trading Price of Novartis India Ltd is ₹ 1055 as of 16 Jul 15:30.
  • The P/E Ratio of Novartis India Ltd changed from 123.1 on March 2020 to 0 on December 2024 . This represents a CAGR of -100.00% over 8 yearsThe P/E Ratio of Sanofi Consumer Healthcare India Ltd changed from 62.6 on December 2024 to 62.6 on December 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Market Cap of Novartis India Ltd changed from ₹ 1240 crore on March 2020 to ₹ 0 crore on December 2024 . This represents a CAGR of -100.00% over 8 yearsThe Market Cap of Sanofi Consumer Healthcare India Ltd changed from ₹ 11347 crore on December 2024 to ₹ 11347 crore on December 2024 . This represents a CAGR of 0.00% over 1 years.
  • The revenue of Novartis India Ltd for the Mar '25 is ₹ 94.51 crore as compare to the Jun '25 revenue of ₹ 0 crore. This represent the growth of 9.2233718E16% The revenue of Sanofi Consumer Healthcare India Ltd for the Mar '25 is ₹ 0 crore as compare to the Jun '25 revenue of ₹ 177.8 crore. This represent the decline of -100%.
  • The ebitda of Novartis India Ltd for the Mar '25 is ₹ 34.54 crore as compare to the Jun '25 ebitda of ₹ 0 crore. This represent the growth of 9.2233718E16% The ebitda of Sanofi Consumer Healthcare India Ltd for the Mar '25 is ₹ 0 crore as compare to the Jun '25 ebitda of ₹ 69.2 crore. This represent the decline of -100%.
  • The net profit of Novartis India Ltd changed from ₹ 20.26 crore to ₹ 29.3 crore over 9 quarters. This represents a CAGR of 17.82% The net profit of Sanofi Consumer Healthcare India Ltd changed from ₹ 45 crore to ₹ 0 crore over 7 quarters. This represents a CAGR of -100.00% .
  • The Dividend Payout of Novartis India Ltd changed from 244.84 % on March 2020 to 0 % on December 2024 . This represents a CAGR of -100.00% over 8 yearsThe Dividend Payout of Sanofi Consumer Healthcare India Ltd changed from 6.06 % on December 2023 to 69.89 % on December 2024 . This represents a CAGR of 239.60% over 2 years.

Share Price

* All values are in Rupees

P/E Ratio Over Time

No data available

Market Cap Over Time

No data available

* All values are in crore

Historical Share Prices

* All values are in Rupees

Revenue Over Time

No data available

* All values are in crore

EBITDA Over Time

No data available

* All values are in crore

Net Profit Over Time

No data available

* All values are in crore

Dividend Payout Over Time

No data available

* All values are in %

About Novartis India Ltd

  • Novartis India Limited (NIL) is a subsidiary of Swiss giant Novartis, the world's second largest pharmaceutical company was incorporated on 13 December 1947.
  • The Company is engaged in manufacturing and marketing of drugs, pharmaceutical products and formulations for consumer healthcare and animal healthcare; it operates into four segments such as Pharmaceuticals, Generics, Over the Trade Counter and Animal Health. The origin of Novartis is linked to the origin of three distinct companies namely Geigy, Ciba, and Sandoz.
  • The history of Geigy goes back to the middle of the 18th century, Ciba was founded around 1860, and Sandoz was set-up in 1886.
  • In 1970 Ciba and Geigy merged to form Ciba-Geigy Ltd. Sandoz and Ciba-Geigy Ltd continued as separate entities for the next 25 years.
  • In 1996, in one of the largest corporate mergers in history Sandoz and Ciba-Geigy Ltd.

About Sanofi Consumer Healthcare India Ltd

  • Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, as part of Sanofi's global strategy to establish a standalone Consumer Healthcare business.
  • This strategic move resulted in the demerger of the Consumer Healthcare business from Sanofi India Limited (SIL) into the Company through a Scheme of Arrangement, thereby creating a distinct legal entity.
  • The Scheme of Arrangement, which was sanctioned by the National Company Law Tribunal, Mumbai (NCLT) enabled the seamless transfer and vesting of all assets, liabilities, and operations of SIL to the Company. Pursuant to the Scheme becoming effective, the Consumer Healthcare Division (CHC) business of Sanofi India Limited (SIL) got demerged into the Company as a going concern through the Scheme of Arrangement and became effective from June 1, 2024.

Novartis India Ltd News Hub

News

Novartis India to discuss results

Novartis India will hold a meeting of the Board of Directors of the Company on 29 July 202...

Read more

01 Jul 2025 10:25

News

Novartis India schedules AGM

Novartis India announced that the 77th Annual General Meeting(AGM) of the company will be ...

Read more

10 May 2025 09:38

News

Board of Novartis India recommends final dividend

Novartis India announced that the Board of Directors of the Company at its meeting held on...

Read more

10 May 2025 09:38

News

Novartis India to announce Quarterly Result

Novartis India will hold a meeting of the Board of Directors of the Company on 9 May 2025....

Read more

28 Mar 2025 09:32

News

Novartis India to hold board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 28 January ...

Read more

28 Dec 2024 09:37

News

Novartis India schedules board meeting

Novartis India will hold a meeting of the Board of Directors of the Company on 25 October ...

Read more

28 Sep 2024 10:07

Sanofi Consumer Healthcare India Ltd News Hub

News

Sanofi Consumer reports 20% YoY fall in Q1 PAT to Rs 50 cr

Revenue from operations fell 22.11% YoY to Rs 172.60 crore in the quarter ended 31 March 2...

Read more

03 May 2025 15:12

News

Sanofi Consumer Healthcare India to convene board meeting

Sanofi Consumer Healthcare India will hold a meeting of the Board of Directors of the Comp...

Read more

26 Apr 2025 10:37

News

Sanofi Consumer Healthcare CFO Maithilee Mistry resigns

According to an exchange filing, Mistry has decided to resign to explore new opportunities...

Read more

07 Apr 2025 12:44

News

Sanofi Consumer Healthcare India AGM scheduled

Sanofi Consumer Healthcare India announced that the 2nd Annual General Meeting(AGM) of the...

Read more

26 Mar 2025 17:41

News

Board of Sanofi Consumer Healthcare India recommends final dividend

Sanofi Consumer Healthcare India announced that the Board of Directors of the Company at i...

Read more

21 Feb 2025 09:40

News

Sanofi Consumer posts PAT of Rs 46 crore in Q3

Total operating expenditure rose by 13.8% YoY to Rs 111.50 crore in Q3 FY25, due to higher...

Read more

21 Feb 2025 10:34

SWOT Analysis Of Novartis India Ltd

Strength

1

S

Weakness

0

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Novartis India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

BlinkX Score for Sanofi Consumer Healthcare India Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

FAQs for the comparison of Novartis India Ltd and Sanofi Consumer Healthcare India Ltd

Which company has a larger market capitalization, Novartis India Ltd or Sanofi Consumer Healthcare India Ltd?

Market cap of Novartis India Ltd is 2,605 Cr while Market cap of Sanofi Consumer Healthcare India Ltd is 11,868 Cr

What are the key factors driving the stock performance of Novartis India Ltd and Sanofi Consumer Healthcare India Ltd?

The stock performance of Novartis India Ltd and Sanofi Consumer Healthcare India Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Novartis India Ltd and Sanofi Consumer Healthcare India Ltd?

As of July 16, 2025, the Novartis India Ltd stock price is INR ₹1055.1. On the other hand, Sanofi Consumer Healthcare India Ltd stock price is INR ₹5153.25.

How do dividend payouts of Novartis India Ltd and Sanofi Consumer Healthcare India Ltd compare?

To compare the dividend payouts of Novartis India Ltd and Sanofi Consumer Healthcare India Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions

Join the

Future of Trading

with BlinkX

#ItsATraderThing

Open Trading Account
Verify your phone
+91
*By signing up you agree to our terms & conditions